Clinical Trial Update: Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intensive versus conventional treatment for primary systemic amyloidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Amyloidosis

Snippet

Sponsor: University Hospital, Limoges | Conditions: Primary Systemic Amyloidosis (AL) | Phase 3 | Status: COMPLETED